Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $131.5000 (-0.49%) ($131.5000 - $131.5000) on Fri. Jan. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.37% (three month average) | RSI | 57 | Latest Price | $131.5000(-0.49%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) SHY(26%) IBB(24%) GDX(22%) SIL(22%) EWY(21%) | Factors Impacting SGEN price | SGEN will decline at least -1.185% in a week (0% probabilities). UUP(-16%) USO(-9%) VIXM(-7%) XLF(-6%) TBT(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.185% (StdDev 2.37%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $131.17(0.25%) | 10 Day Moving Average | $131.49(0.01%) | 20 Day Moving Average | $130.52(0.75%) | To recent high | -4.8% | To recent low | 12.1% | Market Cap | $22.863b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |